tradingkey.logo
tradingkey.logo
Search

FibroGen Ord Shs

KYNB
Add to Watchlist
6.730USD
-0.060-0.88%
Close 07-31 16:00ETQuotes delayed by 15 min
27.24MMarket Cap
0.17P/E TTM

KYNB Balance Sheet

You can check out the annual or quarterly balance sheets of FibroGen Ord Shs here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
Total equity
Cash, cash equivalents and short-term investments
--87.24M
--88.98M
--117.97M
- Cash and cash equivalents
--37.00M
--47.87M
--117.97M
-Short-term investments
--50.24M
--41.11M
----
Receivables
--9.04M
--4.22M
--121.00K
-Accounts and notes receivable
--5.04M
--216.00K
--121.00K
-Other receivables
--4.00M
--4.00M
--0.00
Inventory
--3.38M
--3.74M
--3.86M
Prepaid expenses
--1.14M
--1.01M
--768.00K
Other current assets
--556.00K
--1.12M
--695.00K
Total current assets
--101.36M
--99.07M
--133.42M
Non-current assets
Other non-current assets
--248.00K
--361.00K
--556.00K
Total non-current assets
--8.27M
--20.52M
--3.59M
Total assets
--109.63M
--119.59M
--137.01M
Liabilities
Current liabilities
-Other payables
--0.00
--0.00
----
Accrued expenses
--17.34M
--20.18M
--25.78M
Deferred liabilities
--5.68M
--5.31M
--5.10M
Other current liabilities
--5.68M
--5.31M
--5.10M
Total current liabilities
--28.11M
--29.24M
--35.97M
Non-current liabilities
Long-term debt and lease liabilities
--19.25M
--19.56M
--19.47M
-Long-term debt
--19.25M
--19.56M
--19.47M
Deferred liabilities
--4.08M
--255.00K
--573.00K
Long-term accrued expenses
--67.41M
--65.98M
--63.41M
Other non-current liabilities
--4.15M
--337.00K
--671.00K
Total non-current liabilities
--90.81M
--85.88M
--83.56M
Total liabilities
--118.92M
--115.12M
--119.53M
Shareholders' equity
Common equity
--1.68B
--1.68B
--1.68B
Retained earnings
---1.72B
---1.71B
---1.69B
Capital reserves
--1.68B
--1.68B
--1.68B
Gains losses not affecting retained earnings
---1.89M
---2.18M
---2.21M
Non-controlling interests
--34.51M
--34.51M
--34.51M
Total equity
---9.29M
--4.47M
--17.48M
Currency unit
--USD
--USD
--USD
Audit opinions
----
----
----

FAQs

Which balance sheet metrics matter most when analyzing KYNB stock?

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

What is the difference between assets, liabilities, and shareholders' equity?

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

What is the difference between current and non-current items?

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

How Much Cash Does FibroGen Ord Shs Have?

In its most recent quarterly, FibroGen Ord Shs had 37.00M in cash and cash equivalents.

How Much Are FibroGen Ord Shs's Total Liabilities?

FibroGen Ord Shs reported 115.12M in total liabilities as of the latest reported quarter, including 29.24M in current liabilities and 85.88M in non-current liabilities.

What Are FibroGen Ord Shs's Total Assets?

As of the latest reported quarter, FibroGen Ord Shs's total assets were 119.59M, consisting of 99.07M in current assets and 20.52M in non-current assets.

How Much Shareholders' Equity Does FibroGen Ord Shs Have?

FibroGen Ord Shs reported 4.47M in total shareholders' equity as of the latest reported quarter.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.